Orient Bio's Largest Shareholder, Orient, Increases Stock Ownership Ratio by 2.55 Percentage Points

Orient Bio (002630), a biotechnology company, disclosed on July 23 that its largest shareholder, Orient, increased its stock ownership ratio to 39.65% through a special relationship party's insider purchase. This increase reflects confidence in the company's value. As of July 23, 2026, the total shares held by Orient and seven other special relationship parties amount to 23,506,843 shares, up 1,511,236 shares from July 8, 2026. Orient alone holds 14,231,668 shares (24.00%), while Galaxy holds 1,511,236 shares (2.55%), and other parties hold additional shares. The increase was funded by a 160 million won loan from Orient, with no stock collateral.